Sorry, I don't understand your search. ×
Back to Search Start Over

TG Therapeutics Announces Presentation of Data from the ULTIMATE I and II Phase 3 Trials of BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 75th Annual Meeting

Source :
ENP Newswire. April 26, 2023
Publication Year :
2023

Abstract

ENPNewswire-April 26, 2023--TG Therapeutics Announces Presentation of Data from the ULTIMATE I and II Phase 3 Trials of BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 75th Annual [...]

Subjects

Subjects :
American Academy of Neurology
Briumvi (Medication)

Details

Language :
English
Database :
Gale General OneFile
Journal :
ENP Newswire
Publication Type :
News
Accession number :
edsgcl.747036823

Tools

Authors Abstract Subjects Details